URELLE
Generic: HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Basic Information
Manufacturer
Viatris Specialty LLC
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL
FDA Set ID
1d80a11c-6f86-403b-85d4-32ec1924dbe9
Indications & Usage
INDICATIONS and USAGE: Urelle ® is indicated for the treatment of symptoms of irritative voiding.
Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections.
Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Warnings
WARNINGS: If rapid pulse, dizziness, or blurring of vision occurs, discontinue use immediately.
Patients should be advised that urine will be colored blue when taking this medication.
Do not exceed recommended dosage.
Patients should be advised that urine will be colored blue when taking this medication.
Do not exceed recommended dosage.
Adverse Reactions
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-877-999-8402 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
at 1-877-999-8402 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.